ODYSSEY HEALTH, INC. : Other Events, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Material Event

On November 1, 2022, Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. announced that it has filed for United States and global patent protection on its novel breath-propelled, intranasal brain-drug delivery device ("Nasal Device").

Item 7.01 Regulation FD Disclosure

Attached is a copy of a press release being issued by the Company relating to the above-referenced matter, a copy of which is attached as Exhibit as 99.1 and is hereby incorporated.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.



Number       Exhibit
99.1           Press Release
104          Cover Page Interactive Data File (embedded within the Inline XBRL
             document)

© Edgar Online, source Glimpses